Jula Inrig

Associate Clinical Professor, Medicine
School of Medicine

M.D., Loma Linda School of Medicine, 2000
M.H.S., Duke University, 2006

Phone: (214) 505-6781
Email: jinrig@uci.edu

University of California, Irvine

Irvine, CA 92697
Research Interests
Hypertension in end-stage kidney disease, Diabetic Kidney Disease, Clinical Trials, Anemia in Kidney Disease, CV Outcome Trials
Academic Distinctions
1995 Phi Kappa Phi Honors Society
1999 Loma Linda University School of Medicine Merit Scholarship
1999 Alpha Omega Alpha Honor Society
1999 Excellence in Medicine Marilyn J Herber Scholarship
2000 Donald Griggs Award for Merit, Scholarship and Service
2000 Memorial Achievement Citation from American Medical Women's Association
2004 Earl Dalbey Nephrology Clinical Research Fellow Endowment
2005 NIH Kl2 Mentored Clinical Research Scholar Program
2006 Ralph R Synderman Endowment
2006 Southern Society for Clinical Investigators First Place Young Investigators Award
2008 Marquis Who's Who in America
2008 NIH K23 NHLBI Grant
2010 American Society of Nephrology Dialysis Advisory Grou[
2012 ASN Representative for ACP Subspecialty Society Board
2012 AHA CRP Grant
2012 AHA Kidney in Cardiovascular Disease Council
2013 KDOQI Guidelines on Dialysis Adequacy
2015 Chair of Early Career Leadership Committee for AHA KCVD Council
2006-2008 Instructor in Medicine, Duke University and Duke Clinical Research Institute
2008-present Adjunct Associate in Medicine, Duke University
2008-2012 Assistant Professor of Medicine, University of Texas Southwestern Medical Center
2012-present Senior Medical Director, Quintiles Global Research Organization
2016-present Associate Clinical Professor of Medicine, UC Irvine
Research Abstract
Dr. Inrig is a clinical investigator whose research focuses on hypertension and cardiovascular disease in patients with chronic kidney disease. Dr. Inrig received her medical degree from Loma Linda University and completed her medicine residency and nephrology fellowship at Duke University. Dr. Inrig received a Masters in Clinical Research while at Duke University. She subsequently joined the faculty at Duke and the Duke Clinical Research Institute where she performed outcomes research and managed the daily operations and oversight of clinical trials in nephrology and cardiology. Dr. Inrig remains as adjunct faculty at Duke. In 2008, Dr. Inrig was recruited to UT Southwestern where she performed clinical and translational research and oversaw clinical trials supported by the NIH, industry, and private foundations. Dr. Inrig has dozens of publications in well respected peer-reviewed journals and has presented her work at local, national, and international meetings. Dr. Inrig plays an active role in national societies including the American Society of Nephrology, the National Kidney Foundation, and the American Heart Association, serving on numerous committees and boards. Dr. Inrig also serves on the Inaugural Board of Directors for the Kidney Health Initiative, a public-private partnership with the FDA. More recently, Dr. Inrig joined Quintiles, a Global Clinical Research Organization, as a Senior Medical Director and consultant for the clinical development and execution of nephrology trials.
Graduate Programs
Internal Medicine

Last updated